155 related articles for article (PubMed ID: 37131778)
1. A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity.
Shao H; Li X; Wu P; Chen Z; Zhang C; Gu H
Res Sq; 2023 Apr; ():. PubMed ID: 37131778
[TBL] [Abstract][Full Text] [Related]
2. A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity.
Shao H; Li X; Wu P; Chen Z; Zhang C; Gu H
Reprod Sci; 2023 Dec; 30(12):3661-3676. PubMed ID: 37580647
[TBL] [Abstract][Full Text] [Related]
3. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
[TBL] [Abstract][Full Text] [Related]
5. Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes.
Wang Y; Dai L; Huang R; Li W; Wu W
Front Oncol; 2023; 13():1203351. PubMed ID: 37664030
[TBL] [Abstract][Full Text] [Related]
6. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
Yang W; An L; Li Y; Qian S
Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
[TBL] [Abstract][Full Text] [Related]
7. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
9. A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer.
Pan T; Hu Z; Xu D; Zhou Y; Zhang S; Chen Y
Medicine (Baltimore); 2023 Jun; 102(24):e34018. PubMed ID: 37327286
[TBL] [Abstract][Full Text] [Related]
10. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma.
Zeng C; Liu Y; He R; Lu X; Dai Y; Qi G; Liu J; Deng J; Lu W; Jin J; Liu Q
Front Genet; 2022; 13():935056. PubMed ID: 36092903
[No Abstract] [Full Text] [Related]
12. Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular Carcinoma.
Li F; Xue X
J Oncol; 2023; 2023():4615297. PubMed ID: 36844873
[TBL] [Abstract][Full Text] [Related]
13. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes.
Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q
Front Immunol; 2022; 13():982033. PubMed ID: 36052073
[TBL] [Abstract][Full Text] [Related]
14. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
15. A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis.
Xing T; Hu Y; Wang H; Zou Q
Medicine (Baltimore); 2023 May; 102(19):e33739. PubMed ID: 37171330
[TBL] [Abstract][Full Text] [Related]
16. Identification of a prognostic model based on immune and hypoxia-related gene expressions in cervical cancer.
Wang L; Wang C; He Y; Jin M; Lin L; Jiao X; Hu X; Wang Y
J Obstet Gynaecol; 2023 Dec; 43(2):2277242. PubMed ID: 37938121
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer.
Han C; Deng Y; Yang B; Hu P; Hu B; Wang T; Liu J; Xia Q; Liu X
Front Immunol; 2023; 14():1126902. PubMed ID: 36891298
[TBL] [Abstract][Full Text] [Related]
18. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD
Front Immunol; 2022; 13():908068. PubMed ID: 35898492
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic model based on cellular senescence-related gene signature for bladder cancer.
Luo L; Li F; Gong B; Xi P; Xie W
Front Oncol; 2022; 12():937951. PubMed ID: 36505846
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer.
Dai L; Wang X; Bai T; Liu J; Chen B; Li T; Yang W
Front Genet; 2022; 13():961554. PubMed ID: 35991564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]